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SKIPInsulin resistance is characterized as a pathogenic factor in type 2 diabetes. Despite skeletal muscle being primar-
ily responsible for systemic glucose disposal, the mechanisms underlying the induction of insulin resistance in
skeletal muscle have not been fully elucidated. A number of studies have shown that it is characterized by the in-
hibition of the phosphatidylinositol (PI) 3-kinase signaling pathway. Here, we show that skeletal muscle- and
kidney-enriched inositol polyphosphate phosphatase (SKIP), a phosphatidylinositol-3,4,5-trisphosphate (PIP3)
phosphatase, and glucose-regulated protein 78 (GRP78) are implicated in the inhibition of insulin-dependent
PI 3-kinase signaling in skeletal muscle. Mechanistically, under resting conditions, SKIP forms a complex with
GRP78 at the endoplasmic reticulum (ER). Insulin stimulation facilitates the dissociation of SKIP from GRP78
and its binding to the activated form of Pak1. GRP78 is necessary for membrane localization and Pak1-binding
of SKIP, which facilitates inactivation of the insulin signaling pathway. These ﬁndings underscore the speciﬁc
and prominent role of SKIP and GRP78 in the regulation of insulin-dependent PI 3-kinase signaling in skeletal
muscle.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
In type 2 diabetes mellitus, skeletal muscle cells develop resistance
to insulin and show inhibition of glucose transport [1–3], which play a
major role in the pathogenesis of the disease. Although defective insulin
secretion from β-cells is one of themajor features, skeletal muscle insu-
lin resistance is considered an initial metabolic defect in the develop-
ment of the disease [4,5]. A number of studies have suggested a
relationship between human skeletal muscle insulin resistance and
the pathogenesis of type 2 diabetes [6–8]. A marked decrease in
insulin-induced Akt phosphorylation in skeletal muscle in the normal-
glucose-tolerance offspring of type 2 diabetes parents was observed in
comparison to that in healthy subjects [8]. Therefore, identiﬁcation of
the keymolecules that contribute to the suppression of insulin signaling
should provide important insights for treatment of the disease.lasmic reticulum; SKIP, skeletal
phosphatase; GRP78, glucose-
risphosphate; PI(4,5)P2, phos-
response.In skeletal muscle, insulin binds to the insulin receptor, which leads
to activation of phosphatidylinositol (PI) 3-kinase and an increase in the
level of intracellular phosphatidylinositol 3,4,5-trisphosphate (PIP3).
PIP3 activates Akt2 at the plasma membrane [9], which is necessary
for subsequent glucose uptake into the skeletal muscle [10]. Incorporat-
ed glucose is converted to glycogen for storage or enters the glycolytic
pathway where it is oxidized for energy production. PIP3 phosphatases
hydrolyze PIP3 to PIP2 and attenuate the PI 3-kinase signaling pathway.
Skeletal muscle- and kidney-enriched inositol polyphosphate 5-phos-
phatase (SKIP) is one of the PIP3 phosphatases that negatively regulate
insulin signaling and subsequent glucose incorporation [11–14]. Pps, a
mouse ortholog of SKIP, heterozygous knockoutmice exhibit higher sys-
temic glucose uptake and insulin sensitivity than wild-type mice, with
increased Akt phosphorylation and glucose uptake in skeletal muscle
but not in adipose tissue, and they are resistant to diet-induced insulin
resistance [13]. A hyperinsulinemic-euglycemic clamp study showed
increased rates of glucose infusion and insulin-stimulated glucose
disposal in these mice without any abnormalities in hepatic glucose
production [13]. Rat L6 and mouse C2C12 muscle cell lines have been
extensively used to study insulin signaling in skeletal muscle. Impor-
tantly, upon insulin stimulation, SKIP translocates from the ER to the
membrane rufﬂes in C2C12 cells, where it binds to the activated form
of p21-activated kinase 1 (Pak1) and forms a protein complex with
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Pak1 in C2C12 cells increases insulin-induced Akt2 phosphorylation
[3]. The location of SKIP proximal to these PIP3 effectors determines
the efﬁciency and speciﬁcity of the negative regulation of insulin signal-
ing. Rat L6 cells arewidely used to analyze insulin-mediated glucose up-
take because they express more glucose transporter 4 (GLUT4) protein
than C2C12 cells. Knockdown of SKIP in these cells markedly increases
2-deoxy glucose uptake in response to insulin stimulation [3]. There-
fore, it is likely that SKIP is the speciﬁc regulator for diet-induced insulin
resistance in skeletal muscle among PIP3 phosphatases [14]. In addition
to regulation of insulin action, SKIP mediates skeletal muscle differenti-
ation [15]. Knockdown of SKIP increases insulin-like growth factor-II
(IGF-II) transcription and potentiates the IGF-II–PI3-kinase–Akt–mTOR
auto-regulation loop duringmyogenesis. Expression of SKIP is markedly
increased during differentiation, which leads to inhibition of IGF signal-
ing and termination of differentiation. Further, SKIP likely is a speciﬁc
regulator of myogenesis.
Previous reports have shed light on the link between endoplasmic
reticulum (ER), insulin signaling, and type 2 diabetes [16–18], and the
molecularmechanism of this link has been identiﬁed. Several patholog-
ical stresses disrupt ER homeostasis, named ER stress,which leads to the
accumulation of unfolded proteins in the ER lumen. GRP78 is a molecu-
lar chaperone in the luminal ER [19] that plays a pivotal role in these ER
functions. Recent evidence suggests that GRP78 directly regulates
systemic insulin sensitivity and glucose homeostasis [20]. GRP78
haploinsufﬁciency in mice subjected to ER stress induced by a high-fat
diet (HFD) activates the adaptive unfolded protein response (UPR)
and improves insulin sensitivity with increased insulin-induced Akt
phosphorylation and glucose uptake in the adipose tissue and liver
[21]. Heterozygous SKIP knockout mice exhibit a normal blood glucose
level, but they also exhibit increased insulin signaling and resistance
to HFD-fed conditions, similar to GRP78 heterozygous mice [13]. Fur-
thermore, embryonic ﬁbroblast cells isolated from these mice exhibit
increased insulin-dependent Akt phosphorylation [21]. Taken together,
GRP78 is likely to negatively regulate PI 3-kinase signaling. However,
there are conﬂicting reports on the role of GRP78 in the regulation of
PI 3-kinase signaling. For example, Akt activation is blocked by targeted
knockout of GRP78 in the Pten null prostate epithelium [22]. Therefore,
the molecular mechanisms by which GRP78 regulates PI 3-kinase sig-
naling and insulin action in the skeletal muscle remain to be elucidated.
In this study, we investigated themolecularmechanisms of howGRP78
and SKIP regulate insulin signaling in skeletal muscle.We found that in-
sulin stimulation facilitates the dissociation of SKIP from GRP78, which
allows SKIP to bind to Pak1 and leads to inactivation of insulin signaling.
These results identiﬁed the regulatory role of GRP78 and SKIP insulin-
dependent PI 3-kinase signaling in the skeletal muscle.
2. Materials and methods
2.1. Materials
Antibodies raised against the C-terminus of SKIP were developed in
our laboratory for immunoblotting. Antibodies speciﬁc for Akt, Akt2,
phospho-Akt (Ser-473), phospho-Akt (Thr-308), and Pak1 were
purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-
GRP78 antibody was purchased from BD Biosciences (Franklin Lakes,
NJ, USA). Anti-FLAGM2monoclonal antibody, anti-FLAGM2 agarose af-
ﬁnity gel, insulin, and LY294002 were purchased from Sigma Aldrich
(St. Louis, MO, USA). Methyl-β-cyclodextrin and cytochalasin D were
purchased fromWako Pure Chemical Industries (Osaka, Japan).
2.2. Constructs
SKIP expression vectors were generated by introducing cDNAs
encoding human SKIP into the pGEX (GE Healthcare, Buckinghamshire,
UK), pAcGFP-C1 (Clontech Laboratories, Mountain View, CA, USA), andp3 × FLAG-CMV8 (Sigma Aldrich) vectors. A phosphatase-negative
D310G mutant (D310G), a SKIP C-terminal homology (SKICH) domain
alone mutant (SKIP 318–448), and a mutant lacking SKICH domain
position 1 to 359 (SKIP 1–359) were generated by PCR and were cloned
into expression vectors. pDsRed2-ER expression vectors were pur-
chased from Clontech.
2.3. Cell culture, transfection of plasmids, and RNA interference (RNAi)
The C2C12 murine and L6 rat myoblast cell lines were purchased
from the American Type Culture Collection (Manassas, VA, USA). The
cells were grown in Dulbecco's Modiﬁed Eagle's Medium (DMEM;
Wako Pure Chemical Industries) containing 4.5 g/L glucose, 10% fetal
bovine serum (FBS), and antibiotics (100 μg/mL streptomycin and 100
units/mL penicillin) at 37 °C under an atmosphere of 5% CO2 [15]. For
transfection, cells were cultured to 50% conﬂuence and 1 μg of plasmid
DNA was transfected into the cells. Small interfering RNA (siRNA) du-
plexes were purchased from Life Technologies (Carlsbad, CA, USA).
The following oligonucleotides were used in this study: control, 5′-
GAGTCAACGTCTGCCTGAAGCTTTA-3′; mouse GRP78 #1, 5′-TCTCAAGA
ACCAGTTGGAGATAAA-3′; mouse GRP78 #2, 5′-CCCAACTGGTGAAGAG
GATACATCA-3′; rat GRP78 #1, 5′-TCTTAAGAACCAGATCGGAGATAAA-
3′; rat GRP78 #2, 5′-CCCAACTGGTGAAGAGGATACATCA-3′; mouse
SKIP, 5′-GAGTCAACGTCTGCCTGAAGCTTTA-3′; rat SKIP, 5′-CCATGGAG
CAGTTTCTTCATGGATA-3′; mouse Pak1, 5′-CAAGGTGCTTCAGGCACAGT
GTATA-3′. Twenty nanomoles of control, SKIP, GRP78, or Pak1 siRNA
duplexes were transfected into mouse C2C12 and rat L6 myoblasts.
The cells were cultured in DMEM containing 10% FBS for 48 h and
then serum-starved for another 24 h.
2.4. Immunoblotting
Forty-eight hours after transfection, the C2C12 cells were serum-
starved in serum-freemedium for 24h and then stimulatedwith insulin
(100 nM) at various times. The cells were washed with PBS and lysed
with cell lysis buffer containing 20 mM Tris–HCl (pH 7.5), 150 mM
NaCl, 2 mM EDTA, 5 mM NaF, 1 mM Na3VO4, 1 mM dithiothreitol,
1 mM PMSF, and 1% Triton X-100. The cell lysates were centrifuged at
14,000 ×g for 10 min and the supernatants were solubilized in sodium
dodecyl sulfate (SDS) sample buffer, resolved by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE), and transferred onto a nitrocellulose
membrane. For Western blot analysis, the membrane was incubated
with the primary antibodies at room temperature for 2 h followed by
washing with Tris-buffered saline (25 mM Tris–HCl [pH 7.5], 150 mM
NaCl) containing 0.05% Tween-20. Then, the membrane was incubated
with secondary antibodies at room temperature for 2 h. Densitometry
was used to quantify the protein levels.
2.5. Immunoprecipitation
Cell lysateswere subjected to immunoprecipitation in cell lysis buffer
with various antibodies at 4 °C for 4 h. Twenty-ﬁve micrograms of pro-
tein A-agarose beads (Thermo Fisher Scientiﬁc, Waltham, MA, USA)
were added during the last 2 h of incubation. The beads were washed
5 times with wash buffer (20 mM Tris–HCl [pH 7.5], 150 mM NaCl,
2 mM EDTA, 5 mM NaF, 1 mM Na3VO4, 1 mM DTT, 1 mM PMSF, and
1% Nonidet P-40) before the immunoprecipitates were subjected to
SDS-PAGE. For immunoprecipitation by the FLAG antibody, the lysates
were incubated with anti-FLAG M2 agarose afﬁnity gel beads for 4 h at
4 °C in cell lysis buffer. Then, theywerewashed 5 timeswithwash buffer
before immunoprecipitates were applied to immunoblotting.
2.6. Measurement of Akt2 phosphorylation
Phosphorylation of Akt2 at Thr-309 and Ser-474 was analyzed and
quantiﬁed as described previously [3]. Lysates from C2C12 cells were
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precipitates were subjected to Western blot analysis with anti-
phospho Akt (Thr-308) or anti-phospho Akt (Ser-474) antibodies.
Densitometry was used to quantify the protein levels.
2.7. PIP3 phosphatase assay
3 × FLAG-tagged wild-type SKIP (SKIP WT), SKIP 1–359, and SKIP
318–448 proteins (25 nM each) immunoprecipitated from C2C12 cell
lysates were incubated with PIP3-C8 (Echelon Biosciences, Salt Lake
City, UT, USA) in 40 μL of phosphatase buffer (20 mM Tris–HCl, pH 7.2,
150 mM NaCl, 3 mM MgCl2, and 0.01% Triton X-100) at 37 °C for
10 min. BIOMOL Green reagent (ENZO Life Sciences, Farmingdale, NY,
USA) was used to quantify released free phosphate to measure the
PIP3 phosphatase activity.
2.8. Immunoﬂuorescence
Forty-eight hours after transfection, C2C12 cells were serum-starved
with serum-free medium for 24 h and then stimulated with insulin
(100 nM) for 10–30 min. The cells were ﬁxed with 3.7% formaldehyde,
permeabilizedwith PBS containing 0.2% TritonX-100 for 10min, and in-
cubated with 1% FBS in PBS for 30 min to block non-speciﬁc antibody
binding. The cells were immunostained with the ﬁrst antibody for 1 h
at room temperature and then incubated with ﬂuorescein-labeled sec-
ondary antibodies. F-Actin was visualized by AlexaFluor647-labeled
phalloidin (Life Technologies). After a brief wash with PBS, coverslips
were mounted onto slides using PermaFluor Aqueous Mounting Medi-
um (Thermo Fisher Scientiﬁc) and observed under a FluoView 1000-D
confocal microscope (IX81; Olympus, Tokyo, Japan) equipped with
473-, 568-, and 633-nm diode lasers (Olympus) through an objective
lens (60 Å~ oil immersion objective, NA 1.35; Olympus) and with
FluoView software (Olympus). Acquired images were processed with
Photoshop (Adobe Systems, San Jose, CA, USA).
Live-cell imaging was performed using FluoView 1000-D confocal
microscope (IX81; Olympus, Tokyo, Japan) andwith FluoView software
(Olympus).
2.9. Glucose incorporation analysis
The 2-Deoxyglucose Uptake Measurement Kit (BioVision, Milpitas,
CA, USA) was used to measure glucose incorporation into L6 myoblast
cells following the manufacturer's protocol. Brieﬂy, L6 cells were
stimulated with insulin (10 nM) for 60min and the amount of intracel-
lular 2-deoxyglucose-6-phosphate was measured.
2.10. Statistical analysis
Prior to analysis, we all data were visually inspected to ensure that
they were normally distributed. Differences between treatments were
investigated using Student's t-test. All values are presented as the
mean ± standard error of the mean (SEM).
3. Results
3.1. SKIP interacts with GRP78 via its SKICH domain
SKIP localizes to the ER under basal conditions and translocates to
the membrane rufﬂes in response to insulin, where it negatively regu-
lates insulin-dependent Akt2 phosphorylation through the scaffolding
function of Pak1 [3]. To investigate the mechanisms underlying the
insulin-dependent translocation of SKIP, we sought to identify direct
targets of SKIP in the ER in skeletal muscle. SDS-PAGE following immu-
noprecipitation of C2C12 cell lysates expressing 3 × FLAG-tagged SKIP
revealed a prominent band that was identiﬁed as GRP78 by mass
spectrometric analysis (Fig. 1A), which was not detected in lysatesfrom non-transfected control cells. SKIP consists of a phosphatase
domain and a SKICH domain that is necessary for its localization to
the plasma membrane (Fig. 1B) [2]. The SKICH domain alone (SKIP
318–448) bound to GRP78, while the SKIP 1–359 mutant, which
lacks the SKICH domain but has PIP3 phosphatase activity in vitro (Sup-
plementary Fig. S1), did not bind to GRP78 (Fig. 1C). Immunoprecipita-
tion analysis showed that GRP78 interacts with SKIP WT and the
phosphatase-negative D310G mutant (Supplementary Fig. S1A and B).
To examinewhether GRP78 affects PIP3 phosphatase activity of SKIP, ly-
sates from C2C12 cells expressing 3 × FLAG SKIPWT, D310G, and 1–359
were immunoprecipitated with anti-FLAG agarose beads andwere sub-
jected to a phosphatase assay. Immunoprecipitates of both SKIPWT and
SKIP 1–359 exhibited comparable PIP3 phosphatase activities (Fig. 1D),
indicating that GRP78 does not affect the phosphatase activity of SKIP.
3.2. The SKICH domain of SKIP is required for its localization to the plasma
membrane in response to insulin
It has been reported that the SKICH domain mediates localization of
SKIP to the membrane rufﬂes in response to insulin stimulation [2]. In
C2C12 cells, the SKIP SKICH domain is localized at the membrane rufﬂe
upon insulin stimulation, where it co-localizes with actin [3,23]. We
found that SKIP WT was localized at the cell periphery and co-
localizedwith actin (Fig. 2A). However, SKIP 1–359 showed cytosolic lo-
calization and could no longer localize to the ER (Fig. 2A). This mutant
was not translocated to the plasmamembrane upon insulin stimulation
and did not show co-localizationwith actin (Fig. 2A). To clarify whether
membrane localization of SKIP affects insulin actions, C2C12 cells were
stimulated with 100 nM insulin for 30 min followed by measurement
of Akt2 phosphorylation, and L6 cells were treated with 10 nM insulin
for 60min followed by quantiﬁcation of the glucose uptake [14,23]. Ex-
pression of the SKIP 1–359 mutant did not affect insulin-dependent
Akt2 phosphorylation in C2C12 cells and glucose uptake in L6 cells,
the levels of which were comparable to those in phosphatase-negative
SKIP D310G-expressing cells (Fig. 2B and C). These results indicated
that the phosphatase domain of SKIP faces the cytosol and that
GRP78-binding likely is necessary for ER localization under resting
conditions and insulin-dependent membrane localization of SKIP.
3.3. SKIP interacts with Pak1 at the plasma membrane
SKIP translocates from the ER to the plasma membrane in response
to insulin in C2C12 myoblast cells [12], where it binds to the activated
form of Pak1. This interaction is necessary for the inhibition of insulin
signaling by SKIP. To examinewhether GRP78 regulates this interaction,
3 × FLAG-SKIP WT was expressed in C2C12 cells and lysates were
immunoprecipitated with anti-FLAG antibodies. Time-lapse imaging of
C2C12 cells expressing mCherry-SKIP together with AcGFP-Mem,
encoding a membrane-targeting signal of neuromodulin, showed that
SKIP is not detected at the plasma membrane under unstimulated con-
ditions (Fig. 3A), when SKIP predominantly formed a complex with
GRP78 (Fig. 3B). Accumulation of SKIP at the membrane rufﬂes was ob-
served after insulin stimulation for 10 min (Fig. 3A). After insulin stim-
ulation, co-immunoprecipitation of SKIP with Pak1 was observed;
however, the amount of GRP78 bound to 3 × FLAG-SKIP WT decreased
concomitantly (Fig. 3B). Membrane localization of SKIP was observed
30 min after insulin stimulation, when the amount of GRP78–SKIP
complex was decreased to 50% of that under unstimulated conditions
(Fig. 3B).
3.4. Translocation of SKIP and GRP78 depends on PI 3-kinase activation and
the actin cytoskeleton
Previous results have shown that PIP3–Rac1-dependent activates
Pak1-mediated insulin-dependent translocation of SKIP to membrane
rufﬂes [3]. To examine the involvement of PI 3-kinase signaling and
Fig. 1.GRP78 forms a complexwith SKIP. (A) Identiﬁcation of GRP78 as a SKIP-bindingprotein bymass spectrometry. C2C12 cellswere transfectedwith 3× FLAG-SKIPWT for 48h and the
lysates were immunoprecipitated with anti-FLAG antibody. Non-transfected C2C12 cell lysates were used as a control. Arrows indicate the position of GRP78 and the 3 × FLAG SKIP WT
protein. (B) Schematic representation of the SKIP constructs used in this study. (C) Interaction between the SKIP SKICHdomain andGRP78. C2C12 cellswere transfectedwith the 3× FLAG-
tagged SKIP WT, SKIP 1–359, and SKIP 318–448. The lysates were immunoprecipitated with anti-FLAG antibody and non-transfected C2C12 cell lysates were used as a control. (D) PIP3
phosphatase activity of the SKIP-GRP78protein complex. C2C12 cellswere transfectedwith 3× FLAG-tagged SKIPWT, SKIP 1–359, or SKIP 318–448. The lysateswere immunoprecipitated
with anti-FLAG antibody and were subjected to phosphatase activity assay. Non-transfected C2C12 cell were used as a control.
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LY294002, a PI 3-kinase inhibitor, and cytochalasin D, an actin depoly-
merization inducer, on insulin-dependent membrane localization of
SKIP. Endogenous SKIP andGRP78 are localized to themembrane rufﬂes
upon insulin stimulation in DMSO-treated C2C12 control cells (Fig. 4A).
Treatment of C2C12 cells with the inhibitors (100 nM LY294002 for
40 min or 1 μM cytochalasin D for 60 min) abolished insulin-induced
membrane rufﬂe formation (Fig. 4B and C). In these cells, SKIP and
GRP78 were no longer localized to the plasma membrane (Fig. 4B and
C). Lipid rafts is a cholesterol- or sphingolipid-enriched plasma mem-
brane compartment that is an important for signal transduction, at
which caveolae is invaginated.Weused the cholesterol-depleting action
of methyl-β-cyclodextrin (MβCD) to disrupt lipid rafts and caveolae.
C2C12 cells were treated with 2 mMMβCD for 30 min prior to insulin
stimulation (Fig. 4D). In these cells, SKIP and GRP78 were translocated
to the plasma membrane in response to insulin stimulation (Fig. 4D),
similar to the observations in control C2C12 cells. These results
suggested that translocation of SKIP and GRP78 is dependent on PI 3-
kinase activation and the actin cytoskeleton. Cytochalasin D treatment
increased insulin-induced phosphorylation of Akt2 in C2C12 cells,
which was not altered by MβCD treatment (Fig. 4E).
2.1. GRP78 mediates insulin-dependent membrane localization of SKIP
To examine whether GRP78 mediates the membrane localization of
SKIP, GRP78-targeted siRNAs were transfected into the cells, which
resulted in inhibition of insulin-stimulated localization of SKIP at theplasma membrane (Fig. 5A). In these cells, the GRP78 expression
levels were reduced to approximately 30% (Fig. 5B), while insulin-
induced Akt2 phosphorylation at Ser-474 and Thr-309was signiﬁcantly
increased (Fig. 5B). Additional transfection with SKIP siRNA, which de-
creased SKIP expression by 70%, failed to increase Akt2 phosphorylation
in C2C12 cells (Fig. 5B). Insulin-dependent glucose uptake in L6 cells
was signiﬁcantly increased by GRP78 knockdown, which was not in-
creased by additional silencing of SKIP (Fig. 5C), implying that GRP78
mediates membrane translocation of SKIP. The amount of SKIP-Pak1
complex in response to insulin stimulation was markedly decreased
by knockdown of GRP78 (Fig. 5D). These results suggested that GRP78
mediates the SKIP–Pak1 complex formation at the plasma membrane
and the inhibition of insulin signaling by SKIP.
4. Discussion
SKIP is a PIP3 phosphatase that is abundantly expressed in skeletal
muscle. Our previous ﬁndings have suggested the importance of SKIP
in the regulation of insulin signaling and glucose homeostasis in skeletal
muscle among PIP3 phosphatases [13,14]. Here, we report the role of
SKIP and GRP78 in insulin signaling in skeletal muscle and provide
important clues about the mechanisms by which SKIP controls PI 3-
kinase signaling.
SKIP is interesting with respect to its localization; it exists mainly in
the ER under resting conditions, while it accumulates at the plasma
membrane upon insulin stimulation. Our investigation revealed
that GRP78 forms a complex with SKIP. SKIP consists of 2 domains:
Fig. 2. SKICH domain mutant no longer translocates from the ER to the plasma membrane in response to insulin. (A) Immunoﬂuorescence of pEGFP-SKIP WT, pEGFP-SKIP 1–359, and
DsRed2-ER in insulin-stimulated C2C12 cells. F-actin was visualized by Alexa Fluor 647-labeled phalloidin. Enlarged images of boxed areas are shown. Scale bar, 20 μm. (B) Effect of
the expression of SKIP WT, SKIP D310G, or SKIP 1–359 on the regulation of insulin-dependent Akt2 phosphorylation. Non-transfected C2C12 cell lysates were used as a control. Results
are presented as the mean ± SEM of 3 independent experiments. *P b 0.05, **P b 0.01. (C) Effect of the expression of SKIP WT, SKIP D310G, or SKIP 1–359 on insulin-mediated glucose
uptake into L6 cells. Non-transfected L6 cells were used as control. Results are presented as the mean ± SEM of 3 independent experiments. *P b 0.05, **P b 0.01.
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phosphatases, and the C-terminal SKICH domain that mediates the in-
teraction with GRP78. We have recently shown that the SKICH domain
of SKIP is sufﬁcient for its ER localization [23]. In the current study, we
showed that GRP78 determines the localization of SKIP via the SKICH
domain. A mutant lacking this domain (SKIP 1–359), which could bindto GRP78, did not localize to the ER under resting conditions or to the
plasmamembrane in response to insulin, thus preventing it from regu-
lating insulin-induced Akt2 phosphorylation and glucose uptake. The
cytosolic localization of this mutant suggested that SKIP likely forms a
complex with GRP78 at the ER and that its phosphatase domain faces
the cytosol.
Fig. 3. SKIP andGRP78 translocate fromER to the plasmamembrane in response to insulin. (A) Time lapse imaging of C2C12 cells expressingAcGFP-MemandmCherry-SKIP in response to
insulin stimulation (100 nM) for the indicated periods. Enlarged images of boxed areas are shown. Yellow indicates the region of localization at the plasma membrane. Scale bar: 20 μm.
(B) Co-immunoprecipitation of Pak1-SKIP and GRP78-SKIP complexes from C2C12 cells. C2C12 cells transfected with 3 × FLAG SKIP WT for 48 h were stimulated with insulin for the
indicated periods. Lysates were immunoprecipitated with anti-FLAG antibody and non-transfected C2C12 cell lysates were used as a control.
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ER luminal GRP78. One hypothesis is that SKIP is an ER transmembrane
protein through the SKICHdomain. However, recent results on the crys-
tal structure of theNDP52 SKICH domain have shown that it is a β sand-
wich fold comprising of seven β strands [24], a characteristic that is not
observed in transmembrane proteins. Another possible mechanism is
that SKIP interacts with GRP78 through an unidentiﬁed transmembrane
protein. Insulin stimulation triggers dissociation of SKIP from GRP78,
allowing it to translocate to the plasma membrane.
Further, SKIP interactswith Pak1; in fact, Pak1 andGRP78both inter-
act with the SKICH domain of SKIP [3]. This interaction is necessary for
the negative regulation of insulin signaling by SKIP and facilitates the in-
activation of Akt2 and the subsequent inhibition of insulin signaling.Dissociation of GRP78 from the SKICH domain may allow SKIP to bind
to Pak1 at the plasma membrane. Furthermore, since knockdown of
GRP78 abolished membrane localization of SKIP and led to a signiﬁcant
decrease in insulin-dependent SKIP–Pak1 interaction, GRP78 likely is
necessary to deliver SKIP from the ER to the plasmamembrane. Consis-
tent with this, the SKIP 1–359 mutant no longer localized at the mem-
brane rufﬂes upon insulin stimulation in C2C12 cells. Therefore, the
interaction between SKIP and GRP78 at the ER is necessary for insulin-
induced relocalization of SKIP to the plasma membrane. Recently, it
was shown that GRP78 is localized not only in the luminal ER, but also
at the cell surface, and translocation of GRP78 from the ER to the plasma
membrane has been identiﬁed [25–27]. Protein translocation from the
ER to the plasma membrane is mediated by several mechanisms,
Fig. 4. Effect of inhibitors on insulin-induced translocation of SKIP and GRP78. (A–D) C2C12 cells were pretreatedwith DMSO (A), 100 nMLY294002 (B), 1 μMcytochalasin D (C), or 2mM
methyl-β-cyclodextrin (D) before stimulation with insulin (100 nM, 30 min). Localization of endogenous SKIP and GRP78 is shown. F-actin was visualized by Alexa Fluor 647-labeled
phalloidin. Enlarged images of boxed areas are shown. Scale bar, 20 μm. (E) Phosphorylation of Akt2 at Ser-474 and Thr-309 by insulin stimulation (100 nM, 30 min) in C2C12 cells
pre-treated with DMSO, LY294002, cytochalasin D, and methyl-β-cyclodextrin. Values shown were normalized to total Akt2. Results are presented as the mean ± SEM of 3 independent
experiments. *P b 0.05, **P b 0.01.
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dependent pathways [29]. Our pharmacological experiments provided
evidence that this translocation depends on the activation of PI 3-kinase signaling and the actin cytoskeleton. These results are consistent
with previous results showing that Pak1 activation depends on PIP3 and
Rac1-mediated actin cytoskeletal rearrangement [30] and that insulin-
3199T. Ijuin et al. / Biochimica et Biophysica Acta 1853 (2015) 3192–3201dependent Rac1 activation and activation of Pak1mediate SKIP localiza-
tion at the plasma membrane [3]. Although caveolae are critical for
signal transduction and function as reservoirs of signaling proteinsFig. 5.GRP78mediates insulin-induced SKIP-Pak1 interaction. (A) Immunoﬂuorescence of
endogenous SKIP in control or GRP78 siRNA-transfected C2C12 cells. F-actin was visual-
ized by Alexa Fluor 647-labeled phalloidin. Enlarged images of boxed areas are shown.
Regions of co-localization of SKIP, GRP78, and F-actin are indicated in white. Scale bar,
20 μm. (B) Phosphorylation of Akt2 at Ser-474 and Thr-309 in control-, SKIP-, and
GRP78-siRNAs transfected C2C12 cells upon insulin stimulation (100 nM, 30 min). The
level of GRP78 (upper left) and SKIP (lower left) expression and the relative amount of
phosphorylated Akt2 (right) are shown. Values shown were normalized to total Akt2.
Results are presented as the mean ± SEM of 3 independent experiments. *P b 0.05,
**P b 0.01. (C) Effect of silencing of GRP78 and SKIP on insulin-mediated glucose uptake
into thapsigargin-treated L6 cells. L6 cells transfected with control or GRP78 siRNAs
were treated with insulin for 60 min. Results are presented as the mean ± SEM of 3
independent experiments. *P b 0.05. (D) GRP78 mediates complex formation between
endogenous SKIP and Pak1. C2C12 cells transfected with control or GRP78 siRNAs were
stimulated with insulin for 0 or 30 min. Lysates were immunoprecipitated with anti-SKIP
antibody, and the immunoprecipitates were detected with anti-Pak1 antibodies. The
amount of Pak1 immunoprecipitated with SKIP is shown. Results are presented as the
mean ± SEM of 3 independent experiments. *P b 0.05, **P b 0.01.and as clustering sites for ligand-activated receptors [31], MβCD
treatment did not affect insulin-dependent translocation of SKIP
and GRP78, implying that it is mediated by caveolae-independent
mechanisms. Although the exact molecular mechanisms underlying
the translocation of SKIP and GRP78 to the plasma membrane remain
to be elucidated, insulin-dependent activation of PI 3-kinase–Rac1–
Pak1 signaling is required for localization of SKIP proximal to its sub-
strate PIP3 at the plasmamembrane. In addition to the central regulator
of ER function, our results demonstrated a novel role of GRP78 in the di-
rect regulation of PI 3-kinase signaling. Knockdown of GRP78 increased
insulin-dependent Akt2 phosphorylation and glucose uptake, which
were not altered by additional knockdown of SKIP. In addition, the
SKIP 1–359 mutant no longer localized at the ER and translocated to
the plasmamembrane upon insulin stimulation. Taken together, our re-
sults indicated that GRP78 mediates the spatiotemporal regulation of
SKIP, by determining its localization to the ER and plasma membrane.
Finally, our results provided evidence for the molecular basis of the
regulation of insulin signaling by SKIP and GRP78 in the skeletalmuscle.
SKIP, with its catalytic domain facing the cytosol [11], forms a complex
withGRP78 at the ER under basal conditions. Insulin treatment activates
the PI 3-kinase–Akt signaling pathway, which facilitates glucose uptake
into the cells (Fig. 6A). Pak1 is also activated and concentrated at the
membrane rufﬂes. Upon insulin stimulation, SKIP dissociates from
GRP78 and binds to activated Pak1 at the plasma membrane, and a
SKIP–Pak1–Akt2–PDK1 complex is formed (Fig. 6B). In addition, Pak1
activates PIP3 phosphatase activity of SKIP, leading to rapid and efﬁcient
hydrolysis of PIP3 bound to Akt2 and PDK1 (Fig. 6C). By these mecha-
nisms, SKIP and GRP78 terminate insulin signaling and glucose uptake
into the skeletal muscle cells. Although the elucidation of the processes
by which SKIP is transferred to the plasma membrane and dissociates
from GRP78 will lead to a better understanding of the regulation of in-
sulin action in skeletal muscle, our results suggest that GRP78 and
SKIP could be promising targets for efforts aimed at improving insulin
sensitivity and treating diabetes mellitus.
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